Objective: The objective of the study was to evaluate the efficacy and safety of vaginal misoprostol in termination of first trimester missed abortion.
Methods: This was a prospective study carried out from January 2018 to December 2018 among women of first trimester missed abortion attending the private chamber and in Gyne department of Rangpur Medical College Hospital. The inclusion criteria were gestational age of less than 12 weeks. The exclusion criteria were patients with gestational age more than 12 weeks, bronchial asthma, heart diseases. A total 80 patients at 7-12 weeks of gestation of missed abortion requiring termination of pregnancy were included. Single dose of misoprostol 2 tablets of 800 ugm was placed high in vagina (posterior fornix). Women were advised to come after 7-10 days for followed up.
Result: Successful abortion observed in 74 (92.5%) patients. Six (7.5%) patients needed surgical evaluation due to incomplete abortion and non-responding to vaginal misoprostol.
Conclusion: A single dose of 800 ugm vaginal misoprostol is a safe, effective and economic drug for induction of first trimester missed abortion.